Search Results - "Wiland, A M."

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy by Parker, K., Zagadailov, E. A., Bruno, Amanda S., Wiland, A. M.

“…Background. No studies have evaluated the impact of multiple generic immunosuppression medications on transplant coordinators (TCs) and patients. Methods. A…”
Get full text

Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients by PASSALACQUA, J.-A, WILAND, A. M, FINK, J. C, BARTLETT, S. T, EVANS, D. A, KEAY, S

“…Infection is a frequent postoperative complication in renal transplant recipients. However, little information is available concerning the effect of…”
Get full text

Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation by Wiland, A.M, Fink, J.C, Philosophe, B, Farney, A.C, Schweitzer, E.J, Colonna, J.O, Weir, M.R, Bartlett, S.T

Get full text

Comparison of Azathioprine and Mycophenolate Mofetil for the Prevention of Acute Rejection in Recipients of Pancreas Transplantation by Oh, Jung M., Wiland, Anne M., Klassen, David K., Weidle, Paul J., Bartlett, Stephen T.

“…The study was performed to compare the efficacy and side effects of azathioprine (AZA) and mycophenolate mofetil (MMF) in conjunction with cyclosporine or…”
Get full text

Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation : A retrospective study by PHILOSOPHE, Benjamin, FARNEY, Alan C, SCHWEITZER, Eugene J, COLONNA, John O, JARRELL, Bruce E, KRISHNAMURTHI, Venkatesh, WILAND, Anne M, BARTLETT, Stephen T

“…To compare portal and systemic venous drainage of pancreas transplants and demonstrate an immunologic and survival superiority of portal venous drainage…”
Get full text

In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients by Wiland, A M, Plaisance, K I, Schwalbe, R S

“…We attempted to characterize the susceptibility of high-level, gentamicin-resistant (HLGR, minimum inhibitory concentration [MIC] > 2000 micrograms/ml)…”
Get more information

Purification and Kinetic Characterization of the Mitogen-activated Protein Kinase Phosphatase rVH6 by Wiland, Amy M., Denu, John M., Mourey, Robert J., Dixon, Jack E.

“…The dual specificity protein-tyrosine phosphatase rVH6 belongs to a subfamily of enzymes that have in vivo and in vitro catalytic activity against…”
Get full text

Simultaneous pancreas-kidney (SPK) and pancreas living-donor kidney (SPLK) transplantation at the University of Maryland by Philosophe, B, Farney, A C, Schweitzer, E J, Colonna, J O, Jarrell, B E, Foster, 3rd, C E, Wiland, A M, Bartlett, S T

“…The evolution of enteric and portal venous drainage, better immunosuppression, and better patient care has elevated pancreas transplantation with dramatically…”
Get more information

A Plasmid Purification Scheme for Characterization of Small Fragments Cloned into Vectors by Benoreparsons, M., Wiland, A.M.

Get full text

FAVORABLE LONG TERM RESULTS WITH THYMOGLOBULIN (RATG) INDUCTION IN PANCREAS TRANSPLANTATION by Wiland, A M., Weir, M R., Philosophe, B

Get full text

Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial by WILAND, Anne M, FINK, Jeffrey C, WEIR, Matthew R, PHILOSOPHE, Benjamin, BLAHUT, Steven, WEIR, M. Ryan, COPENHAVER, Beth, BARTLETT, Stephen T

“…Living-donor kidney transplant recipients generally do not receive antibody induction. Induction avoidance may not be appropriate, particularly for…”
Get full text

STEROID WITHDRAWAL IN LIVING DONOR TRANSPLANTATION—RESULTS OF OBSERVATIONAL COHORT STUDY OF THE REGISTRY OF SIMULECT USE IN LIVING TRANSPLANTS (RESULTS) by Wiland, A M., Weir, M R., Fink, J C., Flechner, S, Golconda, M S.

Get full text

Daclizumab induction in solid organ transplantation by Wiland, Anne M, Philosophe, Benjamin

“…Antibody induction therapy is used in solid organ transplantation to prevent rejection in the early postoperative period. It is especially useful in high-risk…”
Get more information